http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201817417-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b6c7ba3c73e37efcd08feacd503a187 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-91 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-022 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-981 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-982 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-19 |
| filingDate | 2016-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c95fde7e5d9719ed20b83b019c3b5aa5 |
| publicationDate | 2018-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201817417-A |
| titleOfInvention | Mixed frozen crystal powder rich in platelet plasma combined with human mesenchymal stem cell secreting factor and preparation method thereof |
| abstract | The invention discloses a mixed frozen crystal powder of platelet-rich plasma combined with human mesenchymal stem cell secretion factors and a preparation method thereof. The steps include: preparing platelet-rich plasma; culturing mesenchymal stem cell secretion factors; lyophilizing and mixing rich Platelet plasma and mesenchymal stem cells secrete factors. The weight percentage of autologous platelet plasma contained in the mixed frozen crystal powder is greater than the weight percentage of mesenchymal stem cell secreted factors. The invention uses autologous blood and human cells as materials to improve human absorption efficiency and safety. The culture medium used is human platelet serum instead of animal fetal bovine serum to reduce protein variation, and freeze-drying technology is used to overcome the effects of heat sensitivity and time-effect. At the same time, the mix of frozen crystal powder can be customized for subsequent use in different environments. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I765305-B |
| priorityDate | 2016-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.